Historical record - last NADAC publication: 5/22/2024
Product Information
CARDIZEM LA 180 MG TABLET is a brand product labeled by Bausch Health US LLC, priced at $3.8314 per EA under NDC 00187204690. Its NADAC has been published 107 times since Apr 8, 2015.
The High Outlier badge above means this manufacturer's average price in the Diltiazem Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
180 mg/1
Manufacturer
Bausch Health US LLCNDC
00187204690
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
5/22/2024
Active Ingredients
DILTIAZEM HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021392On Market Since
12/25/2010
Pharmacological Classes
Price Statistics
The NADAC for CARDIZEM LA 180 MG TABLET has been published 107 times since Apr 8, 2015, and over the history we have for it it has declined 3.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.8314 per EA |
|---|---|
| All-time high | $3.9664 (Mar 16, 2016) |
| All-time low | $3.8276 (Apr 17, 2024) |
| Median price | $3.8314 |
| Average price | $3.8943 |
| Largest weekly change | -3.5% (Apr 17, 2024) |
| Weeks tracked | 107 |
| Tracking since | Apr 8, 2015 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARDIZEM LA 180 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARDIZEM LA 180 MG TABLET, manufactured by Bausch Health US LLC, is $3.8314 per EA (NDC 00187204690), effective May 14, 2025.
How has the price of CARDIZEM LA 180 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARDIZEM LA 180 MG TABLET has declined 3.4%. It has been tracked across 107 weekly CMS publications since Apr 8, 2015.
What are the highest and lowest recorded NADAC prices for CARDIZEM LA 180 MG TABLET?
Since Apr 8, 2015, the NADAC for CARDIZEM LA 180 MG TABLET has ranged from a low of $3.8276 (Apr 17, 2024) to a high of $3.9664 (Mar 16, 2016), with a median of $3.8314 per EA.
Are there cheaper alternatives to CARDIZEM LA 180 MG TABLET?
Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DILTIAZEM 24HR ER 180 MG CAP, is $0.1160 per EA — about 97% below CARDIZEM LA 180 MG TABLET.
Who manufactures CARDIZEM LA 180 MG TABLET?
CARDIZEM LA 180 MG TABLET (NDC 00187204690) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification